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A better understanding of the basis of protective immunity and immunopathologic 
reactions associated with contagious bovine pleuropneumonia (CBPP), caused by 
Mycoplasma mycoides subsp. mycoides small colony (MmmSC), is needed to develop better 
vaccines. Here we report on the characterization of T-cell memory responses associated with 
protective immunity in cattle and their use thereof to identify immuno-active proteins of 
MmmSC. Both effector memory (em) and central memory (cm)-like MmmSC specific CD4+ 
T cells were present ex vivo and capable of proliferation and IFN-γ production upon re-
stimulation in vitro with inactivated MmmSC. It has been shown in mice and humans that 
priming of T(cm) is required for long-lived protective immunity, which is also an essential 
requirement of any improved vaccine against CBPP. Pre-sensitized T-cells were used to 
screen recombinant proteins of MmmSC produced as his-tagged proteins and purified by 
chromatography. Three of them were found to trigger the proliferation of both CD4+ T(em) 
and T(cm) and induce the production of IFN-γ: lipoprotein A (LppA), a glucose-specific 
component of the PTS system (ptsG) and to a lesser extent a substrate-binding component of 
the ABC transporter (ABC). In contrast, although lppQ had no effect on its own, it strongly 
inhibited the proliferation of CD4 in response to MmmSC by a mechanism apparently 
independent of direct cytotoxicity. In conclusion, the T-cell reagents and methodology 
described in this study will help identify immuno-protective antigens of MmmSC that have 
potential for the development of a subunit vaccine against CBPP. In addition, these cellular 
tools can also be used to screen for immuno-inhibitory proteins whose corresponding genes 
could be targets for deletion/inactivation in the aim of developing improved attenuated 
vaccines. 
